Home
Indices
FTSE 100
Risers/Fallers
US Share Prices
Sectors
News
RNS
Watchlist
Portfolio
Login / Register
Close
Company Search
Become a Member
Track your favourite stocks
Create & monitor portfolios
Daily portfolio value
Sign Up
Quickpicks
£
%
Company
Chg
Chg %
Add shares to your
quickpicks to
display them here!
Finance News
*AstraZeneca To Sell Rights To Medicines To Covis Pharma For USD350M
*AstraZeneca To Sell Rights To Medicines To Covis Pharma For USD350M
6th Nov 2018 07:04
Related Shares:
Astrazeneca
FTSE 100 Latest
Value
10,600.53
Change
-2.95